| Particulars |
|
|
|
| Company Name
| GlaxoSmithkline Consumer Healthcare Ltd(Merged)
| Year End
| 201903
|
| Full Year |
| Equity (₹ Cr.) |
42.06 |
B.V. (₹) |
973.50 |
| Sales(₹ Cr.) |
4,782.01 |
NP (₹ Cr.) |
982.52 |
| NP Var (%) |
40.00 |
Div% |
1,050.00 |
| CPS(₹) |
248.00 |
EPS (₹) |
233.60 |
| Traded Value(₹ Lakhs) |
0.00 |
52 Week High |
10,846.00 |
| 52 Week Low |
0.00 |
Price BSE |
2,541.00 |
| Price NSE |
0.00 |
Market Capital (₹ Cr.) |
0.00 |
| P/C Ratio |
0.00 |
P/E Ratio |
0.00 |
| Price Vs.BV |
0.00 |
|
| Latest Quarter |
| Year End |
201912 |
Sales (₹ Cr.) |
1,158.86 |
| NP(₹ Cr.) |
276.63 |
NP Var % |
25.00 |
| Trailing Twelve Months |
| Year End |
201912 |
Sales |
4,984.33 |
| OPM |
25.42 |
NP |
1,155.55 |
| NP Var (%) |
27 |
EPS |
274.74 |
| PE |
0.00 |
|
|